Ephexin1, which is traditionally known for its role in neurophysiological processes and minimal expression outside the nervous system [19, 22, 24], has emerged as a pivotal player in CRC through its overexpression and interaction with the Wnt/β-catenin signaling pathway. This evidence concerns the gene NGEF and colorectal carcinoma.